Skip to main content

Table 1 Classification of patients according to the AFP model before TACE

From: Risk stratification of patients with hepatocellular carcinoma undergoing trans arterial chemoembolization using an alpha-fetoprotein model

AFP model

n = 132

Score

Median

2

Range

0–7

Classification

Low-risk

57 (43.2%)

 Median

0

 Range

0–1

High-risk

75 (56.8%)

 Median

3

 Range

2–7